Air Street Capital

Total investments

25

Average round size

14M

Portfolio companies

18

Rounds per year

5.00

Lead investments

3

Follow on index

0.28

Exits

1

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareArtificial IntelligenceFood and BeverageMachine LearningHealth CareComputer VisionLife ScienceVideoImage Recognition

Investments analytics

Analytics

Total investments
25
Lead investments
3
Exits
1
Rounds per year
5.00
Follow on index
0.28
Investments by industry
  • Artificial Intelligence (11)
  • Machine Learning (8)
  • Biotechnology (8)
  • Software (5)
  • Life Science (4)
  • Show 24 more
Investments by region
  • United States (9)
  • United Kingdom (5)
  • Canada (2)
  • Switzerland (1)
  • France (2)
  • Show 3 more
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Avg. valuation at time of investment
3M
Group Appearance index
0.96

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Profluent Bio 21 Mar 2024 Biotechnology, Health Care, Medical Early Stage Venture 35M United States, California, San Francisco
V7 18 Dec 2020 Software, Artificial Intelligence, Machine Learning, Image Recognition Seed 3M England, London, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.